Overview
About Agios Pharmaceuticals
Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment.
Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives. Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect the priorities of rare disease communities.
Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve.
Review our social media guidelines: https://www.agios.com/community-guidelines/
Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives. Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect the priorities of rare disease communities.
Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve.
Review our social media guidelines: https://www.agios.com/community-guidelines/
Headquarters
Cambridge, MAWebsite
http://www.agios.comCompany Size
501-1,000 employeesIndustry
Pharmaceutical ManufacturingCompany Type
Public CompanyFounded
2008Specialties
Biopharmaceuticals, Cellular Metabolism, and Rare DiseasesJobs
Sr Dir, Gen Mgr & Strategic Ally Lead Intl
Agios Pharmaceuticals
Schwyz, Switzerland
Associate Director, Translational Medicine and Data Science
Agios Pharmaceuticals
Cambridge, MA
Associate Director, Scientific Communications & Publications
Agios Pharmaceuticals
Cambridge, MA
Associate Director, HEOR, Patient-Centered Research
Agios Pharmaceuticals
Cambridge, MA
Senior Project Manager, Patient Advocacy Operations
Agios Pharmaceuticals
Cambridge, MA